Molecular comparison of interval and screen-detected breast cancers

Dane Cheasley; Na Li; Simone M Rowley; Kenneth Elder; G Bruce Mann; Sherene Loi; Peter Savas; David L Goode; Tanjina Kader; Magnus Zethoven; Tim Semple; Stephen B Fox; Jia-Min Pang; David Byrne; Lisa Devereux; Carolyn Nickson; Pietro Procopio; Grant Lee; Siobhan Hughes; Hugo Saunders; Kenji M Fujihara; Keilly Kuykhoven; Jacquie Connaughton; Paul A James; Kylie L Gorringe; Ian G Campbell

Journal article

Molecular comparison of interval and screen-detected breast cancers

Dane Cheasley, Na Li, Simone M Rowley, Kenneth Elder, G Bruce Mann, Sherene Loi, Peter Savas, David L Goode, Tanjina Kader, Magnus Zethoven, Tim Semple, Stephen B Fox, Jia-Min Pang, David Byrne, Lisa Devereux, Carolyn Nickson, Pietro Procopio, Grant Lee, Siobhan Hughes, Hugo Saunders Show all

The Journal of Pathology | WILEY | Published : 2019

DOI: 10.1002/path.5251

University of Melbourne Researchers

Kylie Gorringe Author The Sir Peter MacCallum Department of Oncology

Lisa Devereux Author The Sir Peter MacCallum Department of Oncology

Carolyn Nickson Author Melbourne School of Population and Global Health

Sherene Loi Author The Sir Peter MacCallum Department of Oncology

Dane Cheasley Author The Sir Peter MacCallum Department of Oncology

Related Projects (5)

Improving Early Detection And Management Of Women At Risk Of Developing Interval Breast Cancer

Integration Of Breast Screen With The Epidemiological Molecular And Translational Research Program

Lifepool Is A Powerful And Unique Resource That Will Facilitate The Development And Validation Of New Ideas For Treatment And Early Detection Of Breast Cancer

Translating Molecular Pathology Into Cancer Diagnostics

The aim of this research is focussed on translation of basic science through to the clinic by introducing novel cancer diagnostics and techn..

Improving Population Based Mammographic Screening

Grants

Awarded by Victorian Cancer Agency

Awarded by National Breast Cancer Foundation

Awarded by NHMRC

Awarded by Cancer Australia

Funding Acknowledgements

The authors would like to acknowledge the Bioinformatics and Molecular Genomics Core Facilities of the Peter MacCallum Cancer Centre. This work would not have been possible without financial support by the Victorian Cancer Agency (ECSG15003, DC), the National Breast Cancer Foundation (IF-15-004 and CG-08-02, IGC), the NHMRC (APP1079329 SF) and Cancer Australia (1084963, IGC). The funders had no role in the design and execution of this study.